Numerous reports over the spring and summer have suggested that substance use disorders are on the rise as a result of the uncertainty, mental health challenges and isolation that are part and parcel of life during COVID-19. Excessive alcohol consumption is one of the issues that medical and public health experts are particularly concerned about.
Is CBD medicine or isn’t it? Is it safe? Can it impact a drug test result? Cannabis has been the focus of considerable debate, advocacy, and policy, generating both interest and misinformation. There is a great deal of uncertainty about cannabis and cannabinoid terminology, CBD product content, impact on impairment, local regulations and the law.
In recent weeks, the National Drug & Alcohol Screening Association (NDASA) has hosted a series of COVID-19 Townhall Discussions for its members in the drug and alcohol screening industry. The main takeaways from these meetings? Our members are passionate about the important work they do to keep communities and workplaces safe.